| 1 | Dendrimer Gel Nanoparticles with Dual-Targeting of uPAR and Ribonucleotide Reductase R2 Influence Necrosis, Apoptosis, and Cell Cycle Arrest in Triple-Negative Breast Cancer. (Chuang HY, Huang YW, Yang H) Mol Pharm 2025 Dec 01;22(12):7620-7629 2 Citations |
| 1 | Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors. (Jardim DLF, Millis SZ, Ross JS, Lippman S, Ali SM, Kurzrock R) Oncologist 2023 Feb 08;28(2):e82-e91 10 Citations |
| 1 | eIF5A-Independent Role of DHPS in p21CIP1 and Cell Fate Regulation. (Becker AE, Wu PK, Park JI) Int J Mol Sci 2021 Dec 07;22(24) 5 Citations |
| 3 | Evidence that the acetyltransferase Tip60 induces the DNA damage response and cell-cycle arrest in neonatal cardiomyocytes. (Wang X, Lupton C, Lauth A, Wan TC, Foster P, Patterson M, Auchampach JA, Lough JW) J Mol Cell Cardiol 2021 Jun;155:88-98 12 Citations |
| 1 | Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics. (Jardim DL, Millis SZ, Ross JS, Woo MS, Ali SM, Kurzrock R) Oncologist 2021 Apr;26(4):e715-e718 8 Citations |
| 2 | NOGOB receptor-mediated RAS signaling pathway is a target for suppressing proliferating hemangioma. (Hu W, Liu Z, Salato V, North PE, Bischoff J, Kumar SN, Fang Z, Rajan S, Hussain MM, Miao QR) JCI Insight 2021 Feb 08;6(3) 17 Citations |
| 1 | Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway. (Wu PK, Becker A, Park JI) Int J Mol Sci 2020 Jul 30;21(15) 81 Citations |
| 1 | Rapamycin treatment correlates changes in primary cilia expression with cell cycle regulation in epithelial cells. (Jamal MH, Nunes ACF, Vaziri ND, Ramchandran R, Bacallao RL, Nauli AM, Nauli SM) Biochem Pharmacol 2020 Aug;178:114056 13 Citations |
| 1 | CID-6033590 inhibits p38MAPK pathway and induces S-phase cell cycle arrest and apoptosis in DU145 and PC-3 cells. (Sharma GP, Gurung SK, Inam A, Nigam L, Bist A, Mohapatra D, Senapati S, Subbarao N, Azam A, Mondal N) Toxicol In Vitro 2019 Oct;60:420-436 14 Citations |
| 1 | Defining Reprogramming Checkpoints from Single-Cell Analyses of Induced Pluripotency. (Tran KA, Pietrzak SJ, Zaidan NZ, Siahpirani AF, McCalla SG, Zhou AS, Iyer G, Roy S, Sridharan R) Cell Rep 2019 May 07;27(6):1726-1741.e5 43 Citations |
| 1 | Chronic p27Kip1 Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor. (Patki M, McFall T, Rosati R, Huang Y, Malysa A, Polin L, Fielder A, Wilson MR, Lonardo F, Back J, Li J, Matherly LH, Bepler G, Ratnam M) Sci Rep 2018 Oct 30;8(1):16006 14 Citations |
| 1 | Advanced basal cell cancer: concise review of molecular characteristics and novel targeted and immune therapeutics. (Nikanjam M, Cohen PR, Kato S, Sicklick JK, Kurzrock R) Ann Oncol 2018 Nov 01;29(11):2192-2199 45 Citations |
| 1 | A cancer-associated polymorphism in ESCRT-III disrupts the abscission checkpoint and promotes genome instability. (Sadler JBA, Wenzel DM, Strohacker LK, Guindo-Martínez M, Alam SL, Mercader JM, Torrents D, Ullman KS, Sundquist WI, Martin-Serrano J) Proc Natl Acad Sci U S A 2018 Sep 18;115(38):E8900-E8908 59 Citations |
| 1 | Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer. (Shee K, Jiang A, Varn FS, Liu S, Traphagen NA, Owens P, Ma CX, Hoog J, Cheng C, Golub TR, Straussman R, Miller TW) FASEB J 2019 Feb;33(2):1644-1657 16 Citations |
| 1 | Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer. (Shee K, Yang W, Hinds JW, Hampsch RA, Varn FS, Traphagen NA, Patel K, Cheng C, Jenkins NP, Kettenbach AN, Demidenko E, Owens P, Faber AC, Golub TR, Straussman R, Miller TW) J Exp Med 2018 Mar 05;215(3):895-910 72 Citations |
| 1 | A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses. (Hong SK, Wu PK, Park JI) Cell Signal 2018 Jan;42:11-20 32 Citations |
| 1 | Stepping Out of the Cytosol: AIMp1/p43 Potentiates the Link Between Innate and Adaptive Immunity. (Liang D, Halpert MM, Konduri V, Decker WK) Int Rev Immunol 2015;34(5):367-81 19 Citations |
| 1 | Redeployment of Myc and E2f1-3 drives Rb-deficient cell cycles. (Liu H, Tang X, Srivastava A, Pécot T, Daniel P, Hemmelgarn B, Reyes S, Fackler N, Bajwa A, Kladney R, Koivisto C, Chen Z, Wang Q, Huang K, Machiraju R, Sáenz-Robles MT, Cantalupo P, Pipas JM, Leone G) Nat Cell Biol 2015 Aug;17(8):1036-48 61 Citations |
| 1 | Functional Characterization of Nupr1L, A Novel p53-Regulated Isoform of the High-Mobility Group (HMG)-Related Protumoral Protein Nupr1. (Lopez MB, Garcia MN, Grasso D, Bintz J, Molejon MI, Velez G, Lomberk G, Neira JL, Urrutia R, Iovanna J) J Cell Physiol 2015 Dec;230(12):2936-50 18 Citations |
| 2 | Dickkopf-1, the Wnt antagonist, is induced by acidic pH and mediates epithelial cellular senescence in human reflux esophagitis. (Lyros O, Rafiee P, Nie L, Medda R, Jovanovic N, Schmidt J, Mackinnon A, Venu N, Shaker R) Am J Physiol Gastrointest Liver Physiol 2014 Apr 01;306(7):G557-74 28 Citations |
| 1 | A mortalin/HSPA9-mediated switch in tumor-suppressive signaling of Raf/MEK/extracellular signal-regulated kinase. (Wu PK, Hong SK, Veeranki S, Karkhanis M, Starenki D, Plaza JA, Park JI) Mol Cell Biol 2013 Oct;33(20):4051-67 67 Citations |
| 1 | Geminin is required for zygotic gene expression at the Xenopus mid-blastula transition. (Kerns SL, Schultz KM, Barry KA, Thorne TM, McGarry TJ) PLoS One 2012;7(5):e38009 14 Citations |
| 1 | Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein. (Lee HR, Choi WC, Lee S, Hwang J, Hwang E, Guchhait K, Haas J, Toth Z, Jeon YH, Oh TK, Kim MH, Jung JU) Nat Struct Mol Biol 2011 Nov 06;18(12):1336-44 75 Citations |
